A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

Johanna Inhestern, Orlando Guntinas‐Lichius(Jena University Hospital), Claus Wittekindt(Justus-Liebig-Universität Gießen), Harald Schmalenberg(Heidelberg University), Thomas Kuhnt(Leipzig University), Georg Maschmeyer(Radboud University Medical Center), Nicole Rotter(Heidelberg University), Christina Große-Thie(Universitätsmedizin Rostock), Martin Görner(Klinikum Bielefeld), Markus Jungehülsing, Andreas Dietz(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Holger Sudhoff(Bielefeld University)
Annals of Oncology
April 25, 2017
Cited by 46


Related Papers